Bronchiectasis

February 1, 2018February 1, 2018

FDA Gives Aradigm Recommendations for Resubmitting Bronchiectasis Therapy Application

Bronchiectasis, News

The U.S. Food and Drug Administration has given Aradigm a list of suggestions for resubmitting an application for regulatory review of its bronchiectasis therapy Linhaliq. A review board had recommended against the FDA ... Read more

January 18, 2018January 18, 2018

FDA Advisory Committee Does Not Recommend Approval of Inhalant Linhaliq

Bronchiectasis

The Antimicrobial Drugs Advisory Committee (ADAC) of the U.S. Food and Drug Administration (FDA) did not recommend approval of Aradigm’s Linhaliq for the treatment of non-cystic fibrosis bronchiectasis (NCFBE) patients ... Read more

December 4, 2017December 4, 2017

FDA Advisory Group Sets Jan. 11 Review Date for Linhaliq, Potential Non-CF Bronchiectasis Therapy

Bronchiectasis, News

A committee of the U.S. Food and Drug Administration (FDA) will meet next month to review an application for Linhaliq to be approved for the treatment of patients with non-cystic fibrosis bronchiectasis ... Read more

September 11, 2017September 11, 2017

Study Links Fungus Antibodies with Development of Bronchiectasis in COPD Patients

Bronchiectasis, COPD, News

Researchers have linked the presence of antibodies against the Aspergillus fumigatus (A fum) fungus with the development of bronchiectasis in people with COPD. The study, “Sensitization to Aspergillus fumigatus as a risk factor ... Read more

August 29, 2017August 29, 2017

Three Share British Lung Foundation Grant for Lung Disease Research

Bronchiectasis, COPD, Idiopathic Pulmonary Fibrosis, News

Toby Maher, MD, a professor at Imperial College London and based at the National Heart and Lung Institute, is one of three researchers who were awarded the prestigious Chair in Respiratory Research grant ... Read more

May 4, 2017May 4, 2017

New Study Shows High Mortality, Healthcare Costs in Patients with Non-Tuberculosis Mycobacterial Disease

Bronchiectasis, COPD, News

A new European study indicates the financial burden and mortality associated with non-tuberculosis mycobacterium pulmonary disease (NTM-PD) is higher than previously suspected. The study reporting the findings, “Burden of non-tuberculous ... Read more

February 9, 2017February 9, 2017

SmartVest Airway Clearance System Cuts Bronchiectasis Healthcare Costs, Study Says

Bronchiectasis, News

Electromed’s SmartVest Airway Clearance System can substantially reduce the healthcare services that bronchiectasis patients need, saving them $3,045 annually, a study says. The research, “Cost-Effective Analysis of Using High Frequency Chest Wall ... Read more

December 6, 2016December 6, 2016

Positive Trial Results of Pulmaquin Reported for Non-CF Bronchiectasis Patients with Chronic Lung Infections

Bronchiectasis, News

Aradigm reported positive results from the ORBIT-3 (NCT01515007 ) and ORBIT-4 (NCT02104245) Phase 3 clinical trials assessing Pulmaquin for the treatment of non-cystic fibrosis bronchiectasis (non-CF BE) in patients with chronic lung infection by Pseudomonas aeruginosa bacteria. The pivotal clinical trials ... Read more

October 20, 2016October 20, 2016

#CHEST2016 – Bayer to Present New Data on PAH and Bronchiectasis Therapies

Bronchiectasis, News, Pulmonary Hypertension

Bayer announced it will be giving three oral presentations on lead investigative therapies Adempas (riociguat) for the treatment of pulmonary arterial hypertension (PAH), and ciprofloxacin DPI (dry powder for inhalation) to treat non-cystic ... Read more

October 13, 2016October 13, 2016

Aradigm Partners to Develop Treatments for Resistant Biofilm Lung Infections

Bronchiectasis, Cystic Fibrosis, News

Aradigm Corporation is collaborating with the University of Sydney in Australia to develop nanotechnologies targeting fungal and bacterial biofilms, a common complication of infections associated with chronic diseases like cystic fibrosis ... Read more